Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials
From MaRDI portal
Publication:746638
DOI10.1007/s10985-014-9291-yzbMath1322.62257OpenAlexW1964511345WikidataQ44648755 ScholiaQ44648755MaRDI QIDQ746638
Publication date: 16 October 2015
Published in: Lifetime Data Analysis (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10985-014-9291-y
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Estimation in survival analysis and censored data (62N02) Reliability and life testing (62N05)
Related Items (5)
Comment: Inference after covariate-adaptive randomisation: aspects of methodology and theory ⋮ Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes ⋮ Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment ⋮ Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards ⋮ Landmark estimation of survival and treatment effects in observational studies
Cites Work
- Introduction to empirical processes and semiparametric inference
- Nonparametric Estimation from Incomplete Observations
- Semiparametric Estimation of Treatment Effect in a Pretest‐Posttest Study
- Improving Efficiency of Inferences in Randomized Clinical Trials Using Auxiliary Covariates
- Asymptotic Statistics
- NONPARAMETRIC ANALYSIS OF COVARIANCE FOR HYPOTHESIS TESTING WITH LOGRANK AND WILCOXON SCORES AND SURVIVAL-RATE ESTIMATION IN A RANDOMIZED CLINICAL TRIAL
- Unnamed Item
- Unnamed Item
This page was built for publication: Robust methods to improve efficiency and reduce bias in estimating survival curves in randomized clinical trials